Patients who received subcutaneous 0.05% chlorhexidine gluconate antisepsis during primary total shoulder arthroplasty had a ...

Zoetis launches AI Masses, the new AI-powered cytologic capability for Vetscan Imagyst. News release. Zoetis. June 2, 2025.

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor ...

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced ...

The ACG has released new clinical guidelines for the management of ulcerative colitis and Crohn’s disease in adult ...

IntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, ...

Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the ...

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

More migraine treatments than ever have become available in recent years, with more on the way. Discover the many options ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.